Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Somatostatin (diagnostic use) - Receptors, Somatostatin (analysis)

Terms

35Somatostatin (diagnostic use)
21Receptors, Somatostatin (analysis)
29Radiopharmaceuticals (diagnostic use)
21Prospective Studies
14Receptors, Somatostatin (metabolism)
21Iodine Radioisotopes (diagnostic use)
8Iodobenzenes (diagnostic use)
83-Iodobenzylguanidine

Associations

Freq.WeightAssociation
1313Receptors, Somatostatin (analysis) - Somatostatin (diagnostic use)
1111Radiopharmaceuticals (diagnostic use) - Somatostatin (diagnostic use)
1010Prospective Studies - Somatostatin (diagnostic use)
99Receptors, Somatostatin (metabolism) - Somatostatin (diagnostic use)
88Prospective Studies - Receptors, Somatostatin (analysis)
88Iodine Radioisotopes (diagnostic use) - Somatostatin (diagnostic use)
88Iodine Radioisotopes (diagnostic use) - Iodobenzenes (diagnostic use)
883-Iodobenzylguanidine - Iodobenzenes (diagnostic use)
883-Iodobenzylguanidine - Iodine Radioisotopes (diagnostic use)
77Radiopharmaceuticals (diagnostic use) - Receptors, Somatostatin (metabolism)
77Radiopharmaceuticals (diagnostic use) - Receptors, Somatostatin (analysis)
66Prospective Studies - Radiopharmaceuticals (diagnostic use)
55Iodobenzenes (diagnostic use) - Somatostatin (diagnostic use)
55Iodine Radioisotopes (diagnostic use) - Radiopharmaceuticals (diagnostic use)
553-Iodobenzylguanidine - Somatostatin (diagnostic use)
44Prospective Studies - Receptors, Somatostatin (metabolism)
44Iodine Radioisotopes (diagnostic use) - Prospective Studies
33Iodine Radioisotopes (diagnostic use) - Receptors, Somatostatin (metabolism)

Documents par ordre de pertinence
000175 (1998) E Garin (France) ; A Devillers ; J Le Cloirec ; A M Bernard ; J Lescouarc'h ; J Y Herry ; J C Reubi ; P BourguetUse of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake.
000227 (1994) B Carnaille (France) ; M Nocaudie ; F Pattou ; D Huglo ; M Deveaux ; X Marchandise ; C ProyeScintiscans and carcinoid tumors.
000058 (2009) Eric Nguyen-Khac (France) ; Isabelle Ollivier ; Thomas Aparicio ; Véronique Moullart ; Alexis Hugentobler ; Rachida Lebtahi ; Céline Lobry ; Christiane Susini ; Christian Duhamel ; Séverine Hommel ; Jean François Cadranel ; Jean-paul Joly ; Jean Claude Barbare ; Blaise Tramier ; Jean Louis DupasSomatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.
000125 (2004) Francesco Giammarile (France) ; Claire Houzard ; Claire Bournaud ; Zakia Hafdi ; Genevieve Sassolas ; Francoise Borson-ChazotDiagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
000154 (2000) J L Albérini (France) ; B Meunier ; B Denzler ; A Devillers ; P Tass ; L Dazord ; T Le Simple ; J Laissue ; R de Jong ; J Le Cloirec ; J C Reubi ; P BourguetSomatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
000162 (1999) M Nocaudie (France) ; A Bailliez ; E Itti ; C Bauters ; J L Wemeau ; X MarchandiseSomatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy.
000170 (1999) N Valli (France) ; B Catargi ; N Ronci ; F Leccia ; M Guyot ; P Roger ; D Ducassou ; A TabarinEvaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
000172 (1999) R Lebtahi (France) ; G Cadiot ; N Delahaye ; R Genin ; D Daou ; M C Peker ; D Chosidow ; M Faraggi ; M Mignon ; D Le GuludecDetection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
000182 (1997) F Tenenbaum (France) ; M Ricard[Peroperative detection probes. Evaluation and perspectives in endocrinology].
000186 (1997) C Pérault (France) ; C Schvartz ; H Wampach ; J C Liehn ; M J DelisleThoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
000202 (1996) L Manil (France) ; V Edeline ; J Lumbroso ; H Lequen ; J M ZuckerIndium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
000205 (1996) L Manil (France) ; V Edeline ; J Michon ; S Neuenschwander ; H Lequen ; C Lavocat ; J M ZuckerCould somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)?
000206 (1996) M Nocaudie-Calzada (France) ; D Huglo ; B Carnaille ; C Proye ; X MarchandiseComparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
000223 (1994) L Manil (France) ; B Perdereau ; C Barbaroux ; F BrixyStrong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma.
000060 (2009) Etienne Garin (France) ; Florence Le Jeune ; Anne Devillers ; Marc Cuggia ; Anne-Sophie de Lajarte-Thirouard ; Catherine Bouriel ; Eveline Boucher ; Jean-Luc RaoulPredictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
000106 (2006) Michèle Duet (France) ; Philippe Herman ; Michel Wassef ; Ba Huy Patrice Tran ; Jean-Denis LaredoBone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases.
000140 (2002) Rachida Lebtahi (France) ; Joseph Le Cloirec ; Claire Houzard ; Doumit Daou ; Iradj Sobhani ; Geneviève Sassolas ; Michel Mignon ; Patrick Bourguet ; Dominique Le GuludecDetection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
000142 (2001) R Lebtahi (France) ; B Crestani ; N Belmatoug ; D Daou ; R Genin ; M C Dombret ; E Palazzo ; M Faraggi ; M Aubier ; D Le GuludecSomatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis.
000168 (1999) H Kolesnikov-Gauthier (France) ; D Huglo ; M Nocaudie ; X MarchandiseFactor analysis of dynamic series (FADS) in somatostatin receptor imaging.
000193 (1997) R Lebtahi (France) ; G Cadiot ; L Sarda ; D Daou ; M Faraggi ; Y Petegnief ; M Mignon ; D le GuludecClinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
000207 (1996) E Baudin (France) ; J Lumbroso ; M Schlumberger ; J Leclere ; F Giammarile ; P Gardet ; A Roche ; J P Travagli ; C ParmentierComparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
000211 (1995) F Giammarile (France) ; E Baudin ; F Tenenbaum ; J Lumbroso ; M Schlumberger ; P Rougier ; P Ruffie ; J Guigay ; M L Ducreux ; C ParmentierSomatostatin receptor imaging: a preliminary experience in forty-nine patients.
000221 (1995) F Tenenbaum (France) ; J Lumbroso ; M Schlumberger ; A Mure ; P F Plouin ; B Caillou ; C ParmentierComparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
000046 (2010) F Illouz (France) ; J-L Sadoul ; V Rohmer[Somatostatin receptor-based imaging and therapy of digestive endocrine tumors].
000075 (2008) S Leboulleux (France) ; C Dromain ; A L Vataire ; D Malka ; A Aupérin ; J Lumbroso ; P Duvillard ; D Elias ; D M Hartl ; T De Baere ; J Guigay ; M Schlumberger ; M Ducreux ; E BaudinPrediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.
000076 (2008) Amani Asnacios (France) ; Frédéric Courbon ; Philippe Rochaix ; Eric Bauvin ; Valérie Cances-Lauwers ; Christiane Susini ; Stefan Schulz ; Andrée Boneu ; Rosine Guimbaud ; Louis BuscailIndium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
000085 (2007) Nicolas Aide (France) ; Yves Reznik ; Philippe Icard ; Thierry Franson ; Stéphane BardetParaneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition.
000110 (2005) Delphine Vezzosi (France) ; Antoine Bennet ; Philippe Rochaix ; Frédéric Courbon ; Jannick Selves ; Bernard Pradere ; Louis Buscail ; Christiane Susini ; Philippe CaronOctreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
000114 (2005) Emmanuel Gay (France) ; Jean Philippe Vuillez ; Olivier Palombi ; Pierre Yves Brard ; Pierre Bessou ; Jean Guy PassagiaIntraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas.
000130 (2003) Alexandra Le Duc-Pennec (France) ; Christophe Thol ; Marie Cavarec ; Catherine Le Rest ; Alexandre Turzo ; Philippe Guillo ; Yves BizaisOctreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors.
000135 (2002) M Duet (France) ; E Sauvaget ; J-P Guichard ; B Petelle ; S Ledjedel ; Ph Herman ; P Tran Ba Huy[Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
000136 (2002) Hatem Boulahdour (France) ; Anne-Marie Bertrand ; Sébastien Klingelschmitt ; Boris Rudenko ; Andres Loboguerrero ; Anny-Claude Bidet ; Georges Mantion ; Jean-Claude CardotParathyroid adenoma visualization on octreotide scintigraphy.
000158 (2000) P Weinmann (France) ; B Crestani ; A Tazi ; T Genereau ; H Mal ; M Aubier ; D Valeyre ; J L Moretti ; D Le Guludec ; R Lebtahi111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
000163 (1999) M Duet (France) ; C Ajzenberg ; S Benelhadj ; E Lajeunie ; B Lormeau ; P J Guillausseau ; V Rohmer ; D Vilain ; O Mundler ; A WarnetSomatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
000180 (1998) F Montravers (France) ; C Rousseau ; J D Doublet ; B Gattengo ; S Allard ; P Fouret ; J F Bernaudin ; P Thibault ; J N TalbotIn vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma.
000191 (1997) R Lebtahi (France) ; G Cadiot ; J P Marmuse ; C Vissuzaine ; Y Petegnief ; A Courillon-Mallet ; D Cattan ; M Mignon ; D Le GuludecFalse-positive somatostatin receptor scintigraphy due to an accessory spleen.
000200 (1996) A Mure (France) ; R Lebtahi ; L Sarda ; M Glikmanas ; G Cadiot ; E Brochet ; M Faraggi ; D Le GuludecLeft ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome.
000213 (1995) F Tenenbaum (France) ; J Lumbroso ; M Schlumberger ; B Caillou ; P Fragu ; C ParmentierRadiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
000217 (1995) L Sarda (France) ; M Duet ; J M Zini ; B Berolatti ; S Benelhadj ; G Tobelem ; O MundlerIndium-111 pentetreotide scintigraphy in malignant lymphomas.
000224 (1994) E de Kerviler (France) ; G Cadiot ; R Lebtahi ; M Faraggi ; D Le Guludec ; M MignonSomatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
000225 (1994) M Duet (France) ; O Mundler ; C Ajzenberg ; B Berolatti ; P Chedin ; L Duranteau ; A WarnetSomatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index.
000007 (2013) Pablo Maureira (France) ; Pierre-Yves Marie ; Yihua Liu ; Fengxu Yu ; Sylvain Poussier ; Fatiha Maskali ; Frederique Groubatch ; Gilles Karcher ; Nguyen TranSustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.
000081 (2008) Mitra Ahmadi (France) ; Lucie Sancey ; Arnaud Briat ; Laurent Riou ; Didier Boturyn ; Pascal Dumy ; Daniel Fagret ; Catherine Ghezzi ; Jean-Philippe VuillezChemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.
000087 (2007) Emmanuelle N Sabbah (France) ; Jean Kadouche ; David Ellison ; Ciara Finucane ; Didier Decaudin ; Stephen J MatherIn vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
000093 (2006) Clarisse Dromain (France) ; Eric Baudin[Imaging strategy for staging and follow-up of endocrine tumors].
000102 (2006) Rachida Lebtahi (France) ; Severine Moreau ; Sylvain Marchand-Adam ; Marie-Pierre Debray ; Michel Brauner ; Paul Soler ; Joëlle Marchal ; Olivier Raguin ; Anne Gruaz-Guyon ; Jean-Claude Reubi ; Dominique Le Guludec ; Bruno CrestaniIncreased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
000107 (2006) Laure Sarda-Mantel (France) ; Jean-Baptiste Michel ; François Rouzet ; Geneviève Martet ; Liliane Louedec ; Jean-Luc Vanderheyden ; Florence Hervatin ; Olivier Raguin ; Jean-Marc Vrigneaud ; Ban An Khaw ; Dominique Le Guludec(99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats.
000108 (2005) K Assié (France) ; I Gardin ; P Véra ; I BuvatValidation of the Monte Carlo simulator GATE for indium-111 imaging.
000117 (2005) Julie Guillermet-Guibert (France) ; Hicham Lahlou ; Stéphane Pyronnet ; Corinne Bousquet ; Christiane SusiniEndocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
000121 (2004) Isabelle El Espera (France) ; Cyrille Blondet ; Véronique Moullart ; Lazhar Saïdi ; Eric Havet ; Patrice Mertl ; Brigitte Canarelli ; Jean-Luc Schmit ; Marc-Etienne MeyerThe usefulness of 99mTc sulfur colloid bone marrow scintigraphy combined with 111In leucocyte scintigraphy in prosthetic joint infection.
000134 (2003) Michèle Duet (France) ; Elisabeth Sauvaget ; Boris Pételle ; Nathalie Rizzo ; Jean-Pierre Guichard ; Michel Wassef ; Joseph Le Cloirec ; Philippe Herman ; Patrice Tran Ba HuyClinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
000138 (2002) Cheraz Khélifi Younes (France) ; Raphaël Boisgard ; Bertrand TavitianLabelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.
000144 (2001) L Sarda (France) ; P Colin ; F Boccara ; D Daou ; R Lebtahi ; M Faraggi ; C Nguyen ; A Cohen ; M S Slama ; P G Steg ; D Le GuludecMyocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms.
000147 (2001) P Guitera-Rovel (France) ; J Lumbroso ; M S Gautier-Gougis ; A Spatz ; S Mercier ; A Margulis ; G Mamelle ; F Kolb ; E Lartigau ; M F AvrilIndium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases.
000149 (2001) E Bertin (France) ; N Schneider ; N Abdelli ; H Wampach ; G Cadiot ; A Loboguerrero ; M Leutenegger ; J C Liehn ; G ThiefinGastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy.
000161 (1999) P Fernandez (France) ; M Guyot ; P Mangione ; N Valli ; B Basse-Cathalinat ; D DucassouSubarachnoid-pleural fistula complicating thoracoscopy: value of In-111 DTPA myeloscintigraphy.
000165 (1999) P D Buffaz (France) ; J P Vuillez ; O Chabre ; C Cura ; R Barnoud ; D Pasquier ; A Dupre ; D FagretIn-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.
000169 (1999) F Kedzierewicz (France) ; P Thouvenot ; J Lemut ; A Etienne ; M Hoffman ; P MaincentEvaluation of peroral silicone dosage forms in humans by gamma-scintigraphy.
000173 (1999) I Gardin (France) ; M Faraggi ; D Le Guludec ; B BokCell irradiation caused by diagnostic nuclear medicine procedures: dose heterogeneity and biological consequences.
000174 (1999) L Sarda (France) ; P Assayag ; E Palazzo ; D Vilain ; L Guillevin ; M Faraggi ; O Meyer ; D Le Guludec111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases.
000189 (1997) P Urizzi (France) ; J P Souchard ; C Palevody ; G Ratovo ; E Hollande ; F NepveuInternalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localization.
000192 (1997) J F Payen (France) ; J P Vuillez ; B Geoffray ; J L Lafond ; M Comet ; P Stieglitz ; C JacquotEffects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid.
000194 (1996) D Le Guludec (France) ; G Cadiot ; R Lebtahi ; M Mignon[Detection of endocrine tumors of the digestive tract. Value and limitations of scintigraphy of somatostatin receptors].
000199 (1996) E Baudin (France) ; M Schlumberger ; J Lumbroso ; J P Travagli ; B Caillou ; C ParmentierOctreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan.
000214 (1995) B Meunier (France) ; J Le Cloirec ; L Dazord ; J Leveque ; T Lesimple ; P Tas ; P BourguetPer operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe.
000216 (1995) C Manetti (France) ; J M Le Doussal ; E Rouvier ; A Gruaz-Guyon ; J BarbetIntracellular uptake and catabolism of anti-IgM antibodies and bi-specific antibody-targeted hapten by B-lymphoma cells.
000218 (1995) R Audran (France) ; B Collet ; A Moisan ; L ToujasFate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.
000226 (1994) M Phlipponneau (France) ; M Nocaudie ; J Epelbaum ; Y De Keyzer ; J D Lalau ; X Marchandise ; X BertagnaSomatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
000266 (1991) J P Vuillez (France) ; P Peltier ; J C Mayer ; F Dubois ; A Chetanneau ; P Fumoleau ; A Bertrand ; J F ChatalReproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
000276 (1990) O Loréal (France) ; A Moisan ; J F Bretagne ; J LeCloirec ; J L Raoul ; J Gastard ; J Y HerryScintigraphic assessment of indium-111-labeled granulocyte splenic pooling: a new approach to inflammatory bowel disease activity.
000279 (1990) A Chetanneau (France) ; R P Baum ; P A Lehur ; J C Liehn ; A C Perkins ; R Bares ; P Bourguet ; J Y Herry ; J C Saccavini ; J F ChatalMulti-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
000281 (1990) B Collet (France) ; A Moisan ; S Maros ; L Toujas ; J Y HerryIn vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt).
000282 (1990) A Moisan (France) ; J Lecloirec ; J F Bretagne ; O Loreal ; J L Raoul ; J Y HerryImaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling.
000286 (1989) L Manil (France) ; F Boudet ; P Motte ; P Gardet ; J C Saccavini ; J D Lumbroso ; M Schlumberger ; B Caillou ; J P Bazin ; M RicardPositive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
000287 (1989) J M Le Doussal (France) ; M Martin ; E Gautherot ; M Delaage ; J BarbetIn vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.
000291 (1989) A Rolland (France) ; B Collet ; R Le Verge ; L ToujasBlood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice.
000304 (1987) J C Liehn (France) ; P Hannequin ; S Nasca ; D Lebrun ; A Cattan ; J ValeyreA new approach to image subtraction in immunoscintigraphy: preliminary results.

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014